| Name | Title | Contact Details |
|---|
More than 18 years since the first Green House homes opened, THE GREEN HOUSE® Project (GHP) has come to be recognized as the leader in creating high-quality, cost-effective, and sustainable, human-scale alternatives to the traditional nursing home. The pace of momentum continues to increase, now with the majority of states having Green House homes, and potential of global expansion. By infusing the entire organization with optimal systems and structural changes that create a unified approach to elder-directed care, GHP creates a disruptive and high impact innovation. GHP means much more than simply building a small house, it is a movement that de-institutionalizes, de-stigmatizes, and humanizes care for all elders in need of long-term care.
StemCells, Inc., a biopharmaceutical company, engages in the research, development, and commercialization of cell-based therapeutics and tools for use in stem cell-based research and drug discovery primarily in the United States. Its lead therapeutic product candidate, HuCNS-SC cells (purified human neural stem cells), is in development as a potential treatment for a range of central nervous system disorders. The company has conducted a Phase I clinical trial in Pelizaeus-Merzbacher disease, a fatal myelination disorder in children. It is also conducting a Phase I/II clinical trial in chronic spinal cord injury; and has initiated a Phase I/II clinical trial in dry age-related macular degeneration, as well as is pursuing preclinical studies in Alzheimer’s disease. In addition, the company markets a rage of proprietary cell culture products, research grade human cells, and antibody reagents under the SC Proven brand. The proprietary cell culture products include iSTEM, GS1-R, GS2-M, RHB-A, RHB-Basal, NDiff227, NDiff N2, and NDiff N27 supplements, as well as HEScGRO and ESGRO Complete; and antibody reagents comprise STEM24, STEM101, STEM121, and STEM123, which can be used for cell detection, isolation, and characterization. Further, StemCells is involved in developing and commercializing applications of its technologies to enable stem cell-based research. The company sells its tools and technologies products to researchers at academic institutions, pharmaceutical and biotechnology companies, and government laboratories. StemCells, Inc. was founded in 1988 and is headquartered in Newark, California.
IntelliType Corporation is a La Jolla, CA-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
Aids Project New Haven is a New Haven, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.
PureLine Genetics is a Preston, CT-based company in the Healthcare, Pharmaceuticals, and Biotech sector.